The debate around anticoagulation post-AF ablation revolves around striking the delicate balance between preventing strokes and minimizing bleeding risks. In comparing study outcomes, we will explore the ongoing investigation of how to optimally treat patients.
Ablation is a mainstay of AF treatment, but disagreement persists regarding its use as a first-line option. In comparing study outcomes, we will explore how ablation is evolving and the rationale for it becoming first-line therapy for some patients with this debilitating arrhythmia.